A variety of experimental studies have confirmed that preconditioning the m
yocardium by brief periods of ischemia represents a powerful cardioprotecti
ve effect resulting in a reduction of infarct size. After 15 years of resea
rch in the experimental laboratory, some evidence shows the existence of pr
econditioning in human patients with coronary artery disease: repeated ball
oon inflations before coronary angioplasty induce preconditioning-like effe
cts; moreover, some studies demonstrate better clinical outcome in patients
with angina before acute myocardial infarction, resembling a preconditioni
ng effect. So far, a few drugs have been identified as potential mediators
of preconditioning, eg, adenosine, adenosine receptor agonists, and adenosi
ne triphosphate-sensitive potassium channel openers. Before coronary angiop
lasty and heart surgery, these preconditioning mimetics might be used to pr
otect myocardial tissue by means of preconditioning; Further research is re
quired before preconditioning mimetics could be used for therapy in patient
s with chronic myocardial ischemia. Possible antipreconditioning effects of
several drugs, eg, sulfonylurea drugs have to be considered in the treatme
nt of patients with coronary artery disease. Curr Opin Cardiol 1999, 14:340
-348 (C) 1999 Lippincott Williams & Wilkins, Inc.